This briefing outlines recent proposals to change the current UK drug assessment methods.Jump to full report >>
In 2010, the Government proposed moving towards a broader value-based system for assessing and pricing branded drugs. Such an approach aims to ensure that the price the NHS pays for a medicine better reflects its benefits. This briefing outlines recent proposals to change the current assessment methods.
Authors: Peter Border; Joanna Scales
The Parliamentary Office of Science and Technology produces independent, balanced and accessible briefings on public policy issues related to science and technology.